We are pleased to announce that the AME Medical Journal (AMJ) has attained its first impact factor for the 2024 citation year: 0.5 (Figure 1).
Figure 1 Journal Impact Factor of AMJ
AME Medical Journal is an in international, Open Access, peer-reviewed journal, with a mission to provide high-quality evidence to guide clinical decision making for better global health outcomes. As a member of Committee on Publication Ethics (COPE), AMJ maintains the upmost in ethical publishing and best practices in publication. The scope of AMJ includes: Internal Medicine (Immunology, Pulmonology, Cardiology, Neurology, etc.), Surgery (Heart & Thoracic Surgery, Orthopedics etc.), Oncology (Thyroid Cancer, Colorectal Cancer, Palliative Care etc.), Gynecology & Obstetrics, Pediatrics, Otorhinolaryngology (Ophthalmology etc.), Medical Tests and Health Care (Radiology, Pathology, Laboratory Medicine, Nursing, Alternative Medicine etc.), Health Policy & Methodology Science (Public Health, Epidemiology, Medical Ethics etc.), and Biomedical Science & Technology (Pharmacology, Biomedical Engineering, Bibliometrics etc.).
We strive to follow the best practices in publishing. The announcement of the journal’s first impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in cancer research to bring more exciting content to readers in the coming future.
Editorial Office
AME Medical Journal